Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
New pharmacologic agents for diabetes.
C. J. Bailey
*
*
Corresponding author for this work
School of Biosciences
Aston Research Centre for Health in Ageing
College of Health and Life Sciences
Cell & Tissue Biomedical Research
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New pharmacologic agents for diabetes.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Clinical Trials
25%
Dyslipidemias
38%
Glucagon
41%
Glucagon-Like Peptide 1
46%
Gluconeogenesis
47%
Glucose
24%
glucose utilization inhibitor
79%
Hyperglycemia
35%
Insulin
26%
Insulin Receptor
44%
Insulin Secretion
39%
Islet Amyloid Polypeptide
54%
Pharmaceutical Preparations
16%
Phosphorylation
27%
PPAR alpha
100%
PPAR gamma
87%
pramlintide
67%
Stem Cells
28%
Type 2 Diabetes Mellitus
59%
Weights and Measures
25%